These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38544450)

  • 1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.
    Alrjoub MM; Sindiani A; Alshriedeh O; Amarin Z
    Am J Case Rep; 2021 Aug; 22():e932091. PubMed ID: 34408122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian yolk sac tumour in a girl - case report.
    Sharma C; Shah H; Sisodiya Shenoy N; Makhija D; Waghmare M
    Dev Period Med; 2017; 21(2):101-103. PubMed ID: 28796980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neoadjuvant chemotherapy in the management of advanced ovarian yolk sac tumor.
    Lu Y; Yang J; Cao D; Huang H; Wu M; You Y; Chen J; Lang J; Shen K
    Gynecol Oncol; 2014 Jul; 134(1):78-83. PubMed ID: 24582864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 11. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
    Luo M; He Y; Xie B; Li S; Gan F; Zhang S; Luo P
    Pediatr Surg Int; 2021 Aug; 37(8):1031-1040. PubMed ID: 34031745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of 87 ovarian yolk sac tumor (OYST) patients and molecular characteristics of persistent and recurrent OYST.
    Liang S; Ge H; Zhou S; Tang J; Gu Y; Wu X; Li J
    Gynecol Oncol; 2024 Aug; 187():64-73. PubMed ID: 38733954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
    Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
    Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
    Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
    Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.